The group says that their recommendations are intended to ‘uphold overriding societal goals’ by promoting global justice and human dignity in seeking to ensure that the medical benefits of stem cell research are made widely accessible. These are worthy aims – but someone also needs to produce a plan for how the financial investment in commercial research can be justified, if patent protection were to be relaxed for such stem cell discoveries and products.